48
Views
16
CrossRef citations to date
0
Altmetric
Guideline

Antimicrobial Therapy for Intra-Abdominal Infections: Guidelines from the Infectious Disease Advisory Board (IDAB)

, , , , , , & show all
Pages 2-21 | Published online: 11 Mar 2016

References

  • Bernard G. R., Vincent J. L., Laterre P. F. et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001, 344: 699–709.
  • Bohnen J., Boulanger M., Meakins J. L. et al. Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg, 1983, 118: 285–290.
  • Mosdell D. M., Morris D. M., Voltura A. et al. Antibiotic treatment for surgical peritonitis. Ann Surg, 1991, 214: 543–549.
  • Montravers P., Gauzit R., Muller C. et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis, 1996, 23: 486–494.
  • Falagas M. E., Barefoot L., Griffith J. et al. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis, 1996, 15: 913921.
  • Schein M., Marshall J. Source control. A guide to the management of surgical infections. Heidelberg: Springer Verlag, 2002.
  • Montgomery R. S., Wilson S. E. Intraabdominal abscesses: image-guided diagnosis and therapy. Clin Infect Dis, 1996, 23: 28–36.
  • Wacha H., Hau T., Dittmer R. et al. Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg, 1999, 384: 2432.
  • Grunau G., Heemken R., Hau T. Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg, 1996, 162: 619–625.
  • Calandra T., Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med, 2005, 33: 1538–1548.
  • Nathens A. B., Rotstein O. D., Marshall J. C. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg, 1998, 22: 158–163.
  • Evans H. L., Raymond D. P., Pelletier S. J. et al. Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt), 2001, 2: 255–263.
  • Van der Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother, 1982, 10: 263–270.
  • Gladman M. A., Knowles C. H., Gladman L. J. et al. Intra-oper-ative culture in appendicitis: traditional practice challenged. Ann R Coll Surg Engl, 2004, 86: 196–201.
  • Bilik R., Burnweit C., Shandling B. Is abdominal cavity culture of any value in appendicitis ? Am J Surg, 1998, 175: 267–270.
  • Celik A., Ergun O., Ozcan C. et al. Is it justified to obtain routine peritoneal fluid cultures during appendectomy in children ? Pediatr Surg Int, 2003, 19: 632–634.
  • Dougherty S. H., Saltzstein E. C., Peacock J. B. et al. Perforated or gangrenous appendicitis treated with aminoglycosides. How do bacterial cultures influence management ? Arch Surg, 1989, 124: 1280–1283.
  • Kokoska E. R., Silen M. L., Tracy T. F. Jr. et al. The impact of intraoperative culture on treatment and outcome in children with perforated appendicitis. J Pediatr Surg, 1999, 34: 749–753.
  • Soffer D., Zait S., Klausner J., Kluger Y. Peritoneal cultures and antibiotic treatment in patients with perforated appendicitis. Eur J Surg, 2001, 167: 214–216.
  • Christou N. V., Turgeon P., Wassef R. et al. Management of intraabdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg, 1996, 131: 1193–1201.
  • Hopkins J. A., Lee J. C., Wilson S. E. Susceptibility of intraabdominal isolates at operation: a predictor of postoperative infection. Am Surg, 1993, 59: 791–796.
  • Kune G. A., Burdon J. G. Are antibiotics necessary in acute cholecystitis ? Med J Aust, 1975, 2: 627–630.
  • Hanau L. H., Steigbigel N. H. Acute (ascending) cholangitis. Infect Dis Clin North Am, 2000, 14: 521–546.
  • Andersen B. R., Kallehave F. L., Andersen H. K. Antibiotics versus placebo for prevention of postoperative infection after appen-dicectomy. Cochrane Database Syst Rev, 2003, CD001439.
  • Bozorgzadeh A., Pizzi W. F., Barie P. S. et al. The duration of antibiotic administration in penetrating abdominal trauma. Am J Surg, 1999, 177: 125–131.
  • Nathens A. B. Relevance and utility of peritoneal cultures in patients with peritonitis. Surgical infections, 2001, 2: 153–162.
  • Bilik R. Burnweit C., Shandling B. Is abdominal cavity culture of any value in appendicitis ? Am J of Surgery, 1998, 175: 267270.
  • Dougherty S. H. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis, 1997, 25: S258–261.
  • Chalfine A., Carlet J. Traitement antibiotique des péritonites. JChir, 1999, 136: 15–20.
  • Roststein O. D., Pruett T. L., Simmons R. L. Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis, 1985, 7: 151–170.
  • De Lalla F. Antimicrobial chemotherapy in the control of surgical infections complications. J Chemother, 1999, 11: 440–445.
  • Sotto A., Lefrant J. Y., Fabbro-Peray P. et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J of Antimicr Chemoth, 2002, 50: 569576.
  • Ferzoco L. B., Raptopoulos V., Silen W. Acute diverticulitis. N Engl J Med, 1998, 338: 1521–1526.
  • Cohn S. M., Lipsett P. A., Buchamn T. G. et al. Comparaison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg, 2000, 232: 254–262.
  • Solomkin J. S., Mazuski J. E., Baron E. J. et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis, 2003, 37: 997–1005.
  • Mazuski J. E., Sawyer R. G., Nathens A. B. et al. The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: an executive summary. Surgical Infections, 2002, 3: 161–173.
  • Pederzoli P., Bassi C., Vesentini S. et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet, 1993, 176: 480–483.
  • Sainio V., Kemppainen E., Puolakkainen P. et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet, 1995, 346: 663–667.
  • Schwarz M., Isenmann R., Meyer H. et al. Antibiotic use in necro-tizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr, 1997, 122: 356–361.
  • Delcenserie R., Yzet T., Ducroix J. P. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas, 1996, 13: 198–201.
  • Isenmann R., Runzi M., Kron M. et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology, 2004, 126: 997–1004.
  • Nathens A. B., Curtis J. R., Beale R. J. et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med, 2004, 32: 2524–2536.
  • Baril N. B., Ralls P. W., Wren S. M. et al. Does an infected peri-pancreatic fluid collection or abscess mandate operation ? Ann Surg, 2000, 231: 361–367.
  • Beger H. G., Bittner R., Block S. et al. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastro-enterology, 1986, 91: 433–438.
  • Bradley E. L. 3rd, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg, 1991, 161: 19–24.
  • Buchler M. W., Gloor B., Muller C. A. et al. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg, 2000, 232: 619–626.
  • De Waele J., Blot S., Vogelaers D. et al. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis, 2003, 37: 208–213.
  • Gorbach S. L., Bartlett J. G. Anaerobic infections (three parts). N Engl J Med, 1974, 290: 1177–1184, 1237–1245, 1289–1294.
  • Feigin R. D. Textbook of Pediatric Infectious Diseases, 5th edition, 2004, Saunders.
  • Emil S., Laberge J. M., Mikhail P. et al. Appendicitis in children: a ten-year update of therapeutic recommendations. J Pediatr Surg, 2003, 38: 236–242.
  • Lund D. P., Murphy E. U. Management of perforated appendicitis in children: a decade of aggressive treatment. J Pediatr Surg, 1994, 29: 1130–1133.
  • Neilsen I. R., Laberge J. M., Nguyen L. T. et al. Appendicitis in children: current therapeutic recommendations. J Pediatr Surg, 1990, 25: 1113–1116.
  • Nichols R. L., Smith J. W., Fossedal E. N. et al. Efficacy of parenteral antibiotics in the treatment of experimentally induced intraabdominal sepsis. Rev Infect Dis, 1979, 1: 302–312.
  • Bartlett J. G., Louie T. J., Gorbach S. L. et al. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis, 1981, 3: 535–542.
  • Dougherty S. H. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis, 1997, 25: S258–261.
  • Weinstein W. M., Onderdonk A. B., Bartlett J. G. et al. Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis, 1975, 132: 282–286.
  • Heseltine P. N., Yellin A. E., Appleman M. D. et al. Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis, 1983, 148: 322–329.
  • Calandra T., Bille J., Schneider R. et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet, 1989, 2: 1437–1440.
  • Solomkin J. S., Mazuski J. E., Baron E. J. et al. Infectious Diseases Society of America. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis, 2003, 37: 997–1005.
  • Arguedas A., Sifuentes-Osornio J., Loaiza C. et al. An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections. J Chemother, 1996, 8: 130–136.
  • Brook I. Microbiology and management of intra-abdominal infections in children. Pediatr Int, 2003, 45: 123–129.
  • Collins M. D., Dajani A. S., Kim K. S. et al. Comparison of ampi-cillin/sulbactam plus aminoglycoside vs. ampicillin plus clin-damycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group. Pediatr Infect Dis J, 1998, 17: S15–18.
  • Maltezou H. C., Nikolaidis P., Lebesii E. et al. Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis, 2001, 20: 643–646.
  • Goon H. K., Sabiha P. Ceftazidime/Metronidazole versus Netilmicin/Metronidazole in the treatment of perforated appendicitis in children. Clin Therapeutics, 1990, 12: 54–60.
  • Aronoff S. C., Olson M. M., Gauderer M. W. et al. Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis. J Pediatr Surg, 1987, 22: 861–864.
  • Yellin A. E., Heseltine P. N., Berne T. V. et al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet, 1985, 161: 303–307.
  • Schrayen N., Blumental S., De Laet M.-H. et al. Pseudomonas aeruginosa In Children’s Peritonitis: An Innocent Bystander ?, 45th ICAAC, Washington 2004.
  • Sotto A., Lefrant J. Y., Fabbro-Peray P. et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother, 2002, 50: 569–576.
  • Mosdell D. M., Morris D. M., Fry D. E. Peritoneal cultures and antibiotic therapy in pediatric perforated appendicitis. Am J Surg, 1994, 167: 313–316.
  • Sauerland S., Lefering R., Neugebauer E. A. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev, 2002, CD001546.
  • Andersen B. R., Kallehave F. L., Andersen H. K. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev, 2003, CD001439.
  • Wittman D. H., Schein M. Let us shorten antibiotic prophylaxis and therapy in surgery. Am J Surg, 1996, 172: S26–32.
  • Gorecki W. J., Grochowski J. A. Are antibiotics necessary in non-perforated appendicitis in children ? A double blind randomized controlled trial. Med Sci Monit, 2001, 7: 289–292.
  • Soderquist-Elinder C., Hirsch K., Bergdahl S. et al. Prophylactic antibiotics in uncomplicated appendicitis during childhood — a prospective randomised study. Eur J Pediatr Surg., 1995, 5: 282–285.
  • Mazuski J. E., Sawyer R. G., Nathens A. B. et al. The Surgical Infection Society Guidelines on Antimicrobial Therapy for IntraAbdominal Infections: An Executive Summary. Surg Infect (Larchmt), 2002, 3: 161–173.
  • Bates T., Down R. H. L., Houghton M. C. V. et al. Topical ampi-cillin in the prevention of wound infection after appendicectomy. Br J Surg, 1974, 61: 489–492.
  • King D. R., Browne A. F., Birken G. A. et al. Antibiotic management of complicated appendicitis. J Pediatr Surg, 1983, 18: 945950.
  • Nguyen M. H., Yu V. L., Morris A. J. et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis, 2000, 30: 870–876.
  • Snydman D. R., Jacobus N. V., McDermott L. A. et al. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997–2000. Clin Infect Dis, 2002, 35: S126–134.
  • Solomkin J. S., Reinhart H. H., Dellinger E. P. et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann Surg, 1996, 223: 303–315.
  • Cohn S. M., Lipsett P. A., Buchman T. G. et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg, 2000, 232: 254–262.
  • Stone H. H., Strom P. R., Fabian T. C. et al. Third-generation cephalosporins for polymicrobial surgical sepsis. Arch Surg, 1983, 118: 193–200.
  • Meier D. E., Guzzetta P. C., Barber R. G. et al. Perforated appendicitis in children: is there a best treatment ? J Ped Surg, 2003, 38: 1465–1470.
  • Hoelzer D. J., Zabel D. D., Zern J. T. Determining duration of antibiotic use in children with complicated appendicitis. Pediatr Infect Dis J, 1999, 18: 979–998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.